TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from HLS Therapeutics Inc ( (TSE:HLS) ) is now available.
HLS Therapeutics Inc. reported a strong financial performance for Q3 2025, with a 19% increase in Adjusted EBITDA and a 67% rise in cash from operations. The company secured a new credit facility with improved terms and is preparing for the launch of bempedoic acid in Canada, expected to address significant unmet needs in cardiovascular treatment. Despite challenges in the Canadian market, HLS remains optimistic about future growth, leveraging operational synergies and maintaining a strong balance sheet to explore additional opportunities.
The most recent analyst rating on (TSE:HLS) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on HLS Therapeutics Inc stock, see the TSE:HLS Stock Forecast page.
Spark’s Take on TSE:HLS Stock
According to Spark, TipRanks’ AI Analyst, TSE:HLS is a Neutral.
HLS Therapeutics Inc. has a moderate overall stock score driven primarily by its financial performance and technical analysis. The company’s strong gross margins and positive cash flow trends are offset by significant challenges in revenue growth and profitability. Technical indicators suggest a neutral market sentiment. Valuation is negatively impacted by the current unprofitability and lack of dividend yield.
To see Spark’s full report on TSE:HLS stock, click here.
More about HLS Therapeutics Inc
HLS Therapeutics Inc. is a pharmaceutical company that focuses on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. The company is particularly active in the Canadian and U.S. markets, with products like Vascepa and Clozaril contributing to its portfolio.
Average Trading Volume: 15,651
Technical Sentiment Signal: Hold
Current Market Cap: C$160.7M
See more data about HLS stock on TipRanks’ Stock Analysis page.